EPIDIOLEX® (cannabidiol) oral solution: Now FDA Approved, Pending Rescheduling
Click here to see Press Release.

Sign up here to receive EPIDIOLEX information and availability updates.

News

Greenwich Biosciences Inc., is the US subsidiary of GW Pharmaceuticals plc. For general corporate information, please click here.

Investor Inquiries

Stephen Schultz
Vice President, Investor Relations
Tel: +1 917.280.2424 Direct
Email
Fax: 760.795.2219

Media Inquiries

Stephen Schultz
Vice President, Investor Relations
Tel: +1 917.280.2424 Direct
Email
Fax: 760.795.2219

No recent news to display.